DK0857725T3 - (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler - Google Patents

(N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler

Info

Publication number
DK0857725T3
DK0857725T3 DK97309220T DK97309220T DK0857725T3 DK 0857725 T3 DK0857725 T3 DK 0857725T3 DK 97309220 T DK97309220 T DK 97309220T DK 97309220 T DK97309220 T DK 97309220T DK 0857725 T3 DK0857725 T3 DK 0857725T3
Authority
DK
Denmark
Prior art keywords
pyridinylmethyl
heterocyclic
compounds
ylidenamine
acetylcholine receptor
Prior art date
Application number
DK97309220T
Other languages
English (en)
Inventor
Peter Hans Dorff
Stanley Jung
Steven Wayne Goldstein
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0857725T3 publication Critical patent/DK0857725T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
DK97309220T 1997-02-06 1997-11-17 (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler DK0857725T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3803697P 1997-02-06 1997-02-06

Publications (1)

Publication Number Publication Date
DK0857725T3 true DK0857725T3 (da) 2001-09-24

Family

ID=21897750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97309220T DK0857725T3 (da) 1997-02-06 1997-11-17 (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler

Country Status (10)

Country Link
US (1) US6020335A (da)
EP (1) EP0857725B1 (da)
JP (2) JP3542893B2 (da)
AT (1) ATE203535T1 (da)
CA (1) CA2220438C (da)
DE (1) DE69705817T2 (da)
DK (1) DK0857725T3 (da)
ES (1) ES2159380T3 (da)
GR (1) GR3036626T3 (da)
PT (1) PT857725E (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176141A4 (en) * 1999-03-05 2002-08-14 Suntory Ltd HETEROCYCLIC COMPOUNDS HAVING AN EFFECT ACTIVATING THE NICOTINE ACETYL CHOLINE -g (a) 4-g (b) 2-RECEPTOR
JP2001302635A (ja) * 2000-04-21 2001-10-31 Suntory Ltd 新規複素環化合物
EP1256578B1 (en) * 2001-05-11 2006-01-11 Pfizer Products Inc. Thiazole derivatives and their use as cdk inhibitors
CA2460118A1 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
US20030134844A1 (en) * 2001-10-31 2003-07-17 Pfizer Inc. Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
CN1596263A (zh) 2001-11-30 2005-03-16 辉瑞产品公司 芳基－稠合的氮杂多环化合物
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
ES2331245T3 (es) 2003-07-21 2009-12-28 Pfizer Products Inc. Compuestos azapoliciclicos condensados con heteroarilo que reducen la adiccion a la nicotina.
WO2006006071A1 (en) * 2004-07-07 2006-01-19 Pfizer Products Inc. Resolution of an aryl-fused azapolycyclic compound
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
ES2597843T3 (es) 2005-11-24 2017-01-23 Dompé Farmaceutici S.P.A. Derivados de (R)-arilalquilamino y composiciones farmacéuticas que los contienen
CN103977003A (zh) 2007-04-02 2014-08-13 帕金森氏病研究院 用于降低治疗的副作用的方法和组合物
US20100233503A1 (en) * 2009-03-13 2010-09-16 Zachman Joseph M Panel for a storage container
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230780A (ja) * 1985-04-17 1987-02-09 Ss Pharmaceut Co Ltd １，７−ナフチリジン誘導体及びこれを含有する薬剤
US5814645A (en) * 1993-03-24 1998-09-29 Bayer Aktiengesellschaft Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten

Also Published As

Publication number Publication date
GR3036626T3 (en) 2001-12-31
DE69705817T2 (de) 2001-11-08
US6020335A (en) 2000-02-01
JPH10226684A (ja) 1998-08-25
ES2159380T3 (es) 2001-10-01
JP2004175809A (ja) 2004-06-24
MX9709164A (es) 1998-09-30
EP0857725B1 (en) 2001-07-25
JP3542893B2 (ja) 2004-07-14
PT857725E (pt) 2001-11-30
EP0857725A1 (en) 1998-08-12
CA2220438C (en) 2005-08-16
ATE203535T1 (de) 2001-08-15
DE69705817D1 (de) 2001-08-30
CA2220438A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
DK0857725T3 (da) (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler
WO2002016358A3 (en) Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
NZ504482A (en) Aryl fused azapolycyclic compounds and pharmaceuticals thereof which bind to neuronal nicotinic acetylcholine specific recpetor sites and are useful for modulating cholinergic function
IS6459A (is) Arýl sambrædd azapólýsýklísk efnasambönd
ATE180780T1 (de) 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
AP9701125A0 (en) Nicotinic agents in addiction therapy.
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
JP2003513071A5 (da)
ATE202354T1 (de) Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz
NO921490L (no) 1-(pyrido(3,4-b)-1,4-oksazinyl-4-yl)-1h-indoler, mellomprodukter og fremgangsmaate for fremstilling derav samt anvendelse som medikamenter
HU911568D0 (en) Process for producing piperidyl-oxy and quinuclidine-oxyzole derivatives and pharmaceutical preparatives containing said compounds
WO2008092877A3 (en) 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
GR3034499T3 (en) Optically active imidazolidinone derivative and process for producing the same
DK1254905T3 (da) 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet
EP1034783A4 (en) AMIDE DERIVATIVES
GB0428232D0 (en) Compounds
TW200714282A (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
NZ334553A (en) N-(2-Benzothiazolyl) piperidine-1 ethanamine derivatives and pharmaceutical use
AU633791B2 (en) 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
JP2003513072A5 (da)
GR3017801T3 (en) Flavone derivatives.
WO2002088134A3 (en) Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
WO2007080159A3 (en) Pyridine-, isoxazole, thiophenecarboxamide compounds having activity at the glycine transporter glyt1 and uses thereof
HU912674D0 (en) Derivatives of 1-(pyridyl-alkyl)-1h-indole or -indole and process for producing said compounds